Stephen Marcella
Overview
Explore the profile of Stephen Marcella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Orme M, Bentley R, Marcella S, Peck-Radosavljevic M, Perard R, Wedemeyer H, et al.
Adv Ther
. 2022 Jul;
39(9):4169-4188.
PMID: 35836089
Introduction: Lusutrombopag is an oral thrombopoietin receptor agonist (TPO-RA). Clinical trials have shown lusutrombopag's efficacy in reducing need for preoperative platelet transfusion in patients with chronic liver disease (CLD) and...
2.
Collins D, Marcella S, Campbell M, Riley T
Anaerobe
. 2022 Feb;
74:102528.
PMID: 35104667
Objectives: Increasing incidence rates of Clostridium difficile infection (CDI) and outbreaks of emerging strains have highlighted the need for continuous monitoring and surveillance of CDI in Australia. Active surveillance captures...
3.
Basu A, Prabhu V, Dorr M, Golan Y, Dubberke E, Cornely O, et al.
Open Forum Infect Dis
. 2018 Nov;
5(11):ofy218.
PMID: 30460321
Background: Patients with recurrent infection (rCDI) are more likely to have a hospital readmission and spend increased time in inpatient settings compared with patients with primary CDI. MODIFY I and...
4.
Zilberberg M, Nathanson B, Marcella S, Hawkshead 3rd J, Shorr A
Medicine (Baltimore)
. 2018 Sep;
97(36):e12212.
PMID: 30200134
Recurrent Clostridium difficile infection (rCDI) requiring rehospitalization contributes to poor outcomes, which may differ between patients hospitalized with versus for it.We performed a multicenter retrospective cohort study of rehospitalized adults...
5.
Prabhu V, Cornely O, Golan Y, Dubberke E, Heimann S, Hanson M, et al.
Clin Infect Dis
. 2018 Jul;
65(7):1218-1221.
PMID: 30060024
NCT01241552 (MODIFY I) and NCT01513239 (MODIFY II).
6.
Prabhu V, Dubberke E, Dorr M, Elbasha E, Cossrow N, Jiang Y, et al.
Clin Infect Dis
. 2017 Nov;
66(3):355-362.
PMID: 29106516
Background: Clostridium difficile infection (CDI) is the most commonly recognized cause of recurrent diarrhea. Bezlotoxumab, administered concurrently with antibiotics directed against C. difficile (standard of care [SoC]), has been shown...
7.
Kuntz J, Baker J, Kipnis P, Li S, Liu V, Xie Y, et al.
Infect Control Hosp Epidemiol
. 2016 Oct;
38(1):45-52.
PMID: 27760583
BACKGROUND Considerable efforts have been dedicated to developing strategies to prevent and treat recurrent Clostridium difficile infection (rCDI); however, evidence of the impact of rCDI on patient healthcare utilization and...
8.
Biedenbach D, Badal R, Huang M, Motyl M, Singhal P, Kozlov R, et al.
Infect Dis Ther
. 2016 Jul;
5(3):405.
PMID: 27424199
No abstract available.
9.
Biedenbach D, Badal R, Huang M, Motyl M, Singhal P, Kozlov R, et al.
Infect Dis Ther
. 2016 Jun;
5(2):139-53.
PMID: 27287766
Introduction: Bacterial infections that cause community-acquired urinary tract infections (CA-UTI) and upper respiratory tract infections (CA-URTI) are most frequently treated empirically. However, an increase in antimicrobial resistance has become a...
10.
Pinto C, Marcella S, August D, Holland B, Kostis J, Demissie K
BMC Cancer
. 2013 Nov;
13:519.
PMID: 24180710
Background: Given their frequency of occurrence in the United States, cancer and heart disease often coexist. For patients requiring open-heart surgery, this raises concern that the use of cardiopulmonary bypass...